Ondine Biomedical (FRA:VF5) Common Stock: €178.41 Mil (As of Dec. 2025)


FRA:VF5 Ondine Biomedical Inc FRA:VF5
47 GF Score
Price €0.15
View Full Analysis

What is Ondine Biomedical Common Stock?

Ondine Biomedical FRA:VF5 47 Common Stock is €178.41 Mil as of Dec. 2025. GuruFocus rates FRA:VF5 with a GF Score™ of 47/100.

Ondine Biomedical's quarterly common stock declined from Dec. 2024 (€176.02 Mil) to Jun. 2025 (€170.60 Mil) but then increased from Jun. 2025 (€170.60 Mil) to Dec. 2025 (€178.41 Mil).

Ondine Biomedical's annual common stock increased from Dec. 2023 (€163.80 Mil) to Dec. 2024 (€176.02 Mil) and increased from Dec. 2024 (€176.02 Mil) to Dec. 2025 (€178.41 Mil).

Ondine Biomedical Common Stock Historical Data

* Premium members only.

The historical data trend for Ondine Biomedical's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ondine Biomedical Common Stock Chart

Ondine Biomedical Annual Data
Trend Dec10 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 162.51 163.33 163.80 176.02 178.41

Ondine Biomedical Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 163.80 165.96 176.02 170.60 178.41
FRA:VF5
47GF Score
Ondine Biomedical Inc FRA:VF5
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ondine Biomedical Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €178.41 Mil mean?
Ondine Biomedical (FRA:VF5) has a Common Stock of €178.41 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Ondine Biomedical and its competitors.
Is Ondine Biomedical's Common Stock too high?
Ondine Biomedical's current Common Stock is €178.41 Mil. Overall, Ondine Biomedical has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Ondine Biomedical's Common Stock compare to VRTX and REGN?
Ondine Biomedical's Common Stock of €178.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Ondine Biomedical and its competitors. Ondine Biomedical's current Common Stock is €178.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ondine Biomedical stock overvalued right now?
Ondine Biomedical (FRA:VF5) has a current Common Stock of €178.41 Mil. The current Common Stock is €178.41 Mil. Ondine Biomedical's overall GF Score™ is 47/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Ondine Biomedical (FRA:VF5), the current Common Stock is €178.41 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ondine Biomedical Business Description

Address 1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6
Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.
47GF Score

Get the complete analysis for FRA:VF5

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.15
Price